Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 3, 2019
Patent Application Number
15875106
Date Filed
January 19, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
Compound that is an inhibitor of at least one of the A2A and A2B adenosine receptors, and compositions containing the compound and methods for synthesizing the compound, are described herein. The use of such compound and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by the adenosine A2A receptor and/or the adenosine A2B receptor.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
